Changes in the Schedule Since Last Release
• A new footnote to links for the full ACIP vaccine recommendations and where to find additional information on specific vaccine recommendations for travelers.
• Tdap and Td vaccines - Footnote for updated to indicate:
    ° Tdap vaccine is recommended for all persons who are close contacts of infants younger than 12 months of age (e.g., parents, grandparents, and child-care providers) and who have not received Tdap previously.
    ° Tdap vaccine is recommended for pregnant women during later pregnancy (>20 weeks gestation).
    ° Other adults who are close contacts of children younger than 12 months of age continue to be recommended to receive a one-time dose of Tdap vaccine.
• HPV vaccine - Footnote updated to include routine vaccination of males 11–12 years of age, with catch-up vaccination recommended for males 13–21 years of age. Also now recommended for previously unvaccinated males 22–26 years of age who are immunocompromised, or who test positive for human immunodeficiency virus (HIV) infection, or who have sex with men.
• Hep B vaccine - Footnote updated to include the recommendation to vaccinated adults younger than 60 years old who have diabetes, as soon as possible after diabetes is diagnosed. Also now recommended at the discretion of the treating clinician for adults with diabetes who are 60 years or older based on a patient's likely need for assisted blood glucose monitoring, likelihood of acquiring hepatitis B, and likelihood of immune response to vaccination.
• Zoster vaccine – Notes recently approved by FDA for administration to persons 50 years of age and older; however, ACIP continues to recommend that vaccination begin at age 60 years.
• Influenza vaccine - Footnote revised to specify age indications for the different licensed formulations of trivalent inactivated influenza vaccine (TIV).
• MMR vaccine - Footnote simplified to focus only on routine use of this vaccine in adults. Readers referred to ACIP MMR and health-care personnel recommendations regarding the use of MMR vaccine in outbreak settings.
• MCV4 and MPSV4 vaccines - Specific information added about for specific age and risk groups.